Get the Stockscreener App
1.76
0.57%
0.01
After Hours:
1.71
-0.05
-2.84%
Equillium Inc stock is traded at $1.76, with a volume of 166.26K.
It is up +0.57% in the last 24 hours and up +18.92% over the past month.
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.
See More
Previous Close:
$1.75
Open:
$1.75
24h Volume:
166.26K
Relative Volume:
0.27
Market Cap:
$107.17M
Revenue:
$45.91M
Net Income/Loss:
$-4.62M
P/E Ratio:
-12.55
EPS:
-0.1402
Net Cash Flow:
$-21.51M
1W Performance:
+1.44%
1M Performance:
+18.92%
6M Performance:
-7.85%
1Y Performance:
+144.44%
1-Day Range:
$1.665
$1.82
1-Week Range:
$1.665
$1.94
52-Week Range:
$0.27
$2.35
Equillium Inc Stock (EQ) Company Profile
Name
Equillium Inc
Sector
Industry
Phone
(858) 412-5302
Address
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA
Compare EQ vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EQ
Equillium Inc
|
1.76 | 106.56M | 45.91M | -4.62M | -21.51M | -0.1402 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-29-21 | Resumed | Stifel | Buy |
| Sep-15-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-14-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-10-20 | Resumed | Stifel | Buy |
| Feb-22-19 | Initiated | SVB Leerink | Outperform |
View All
Equillium Inc Stock (EQ) Latest News
EQ Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Volume Report: Can Equillium Inc withstand a market correctionJuly 2025 WrapUp & Real-Time Market Trend Scan - baoquankhu1.vn
EQ Technical Analysis & ETF Price Forecast - Intellectia AI
Short Interest in Equillium, Inc. (NASDAQ:EQ) Expands By 47.0% - MarketBeat
Equillium (NASDAQ:EQ) Upgraded at Zacks Research - Defense World
Equillium (NASDAQ:EQ) Stock Rating Upgraded by Zacks Research - MarketBeat
Equillium (NASDAQ:EQ) Downgraded by Wall Street Zen to “Sell” - Defense World
Equillium (NASDAQ:EQ) Downgraded by Wall Street Zen to "Sell" - MarketBeat
EQ Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Equillium: Multi-Cytokine Platform To Go Beyond Scope Of EQ504 For UC (NASDAQ:EQ) - Seeking Alpha
Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference - The Manila Times
Stifel Nicolaus Initiates Coverage on Equillium (NASDAQ:EQ) - MarketBeat
Biotech Equillium offers investor meetings at Leerink 2026 conference - Stock Titan
Stifel initiates Equillium stock with buy rating on IBD potential - Investing.com Australia
Aug Drivers: What is the next catalyst for IPGPMarket Trend Review & Real-Time Buy Signal Alerts - baoquankhu1.vn
Stifel initiates Equillium stock with buy rating on IBD potential By Investing.com - Investing.com Canada
Equillium (EQ) SVP Zedelmayer sells $328k in shares By Investing.com - Investing.com India
Equillium (EQ) SVP Zedelmayer sells $328k in shares - Investing.com
Equillium (NASDAQ:EQ) COO Sells $327,249.12 in Stock - MarketBeat
Equillium (EQ) COO Zedelmayer sells 185,937 shares after exercising stock options - Stock Titan
Fundamentals Check: Can Equillium Inc lead its sector in growth2025 Technical Patterns & Verified Momentum Stock Ideas - baoquankhu1.vn
How sensitive is Equillium Inc. to inflationQuarterly Portfolio Report & Fast Gain Swing Alerts - mfd.ru
Will Equillium Inc. stock gain from strong economyWeekly Earnings Recap & Stock Timing and Entry Methods - mfd.ru
Equillium Conference: EQ504 Targets Ulcerative Colitis Ahead of Mid-Year Phase 1 Start - Defense World
What’s next for Equillium Inc. stockJuly 2025 Opening Moves & High Accuracy Buy Signal Tips - mfd.ru
Can Equillium Inc. stock deliver strong Q4 earningsJuly 2025 Sector Moves & Verified Chart Pattern Signals - mfd.ru
Volume Recap: Is Equillium Inc forming a double bottom2025 Earnings Impact & Community Shared Stock Ideas - baoquankhu1.vn
Equillium, Inc. (NASDAQ:EQ) Short Interest Up 32.2% in January - MarketBeat
Equillium reports inducement grants under Nasdaq Listing Rule - marketscreener.com
Equillium Reports Inducement Grants Under Nasdaq Listing Rule - TradingView
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Aug Gainers: Can AudioEye Inc be the next market leaderRecession Risk & AI Powered Market Trend Analysis - baoquankhu1.vn
Celiac Disease Pipeline 2025: FDA Updates, Therapy Innovations, And Clinical Trial Landscape Analysis By Delveinsight AMYRA Biotech AG, Equillium Bio., Chugai Pharmaceutical, Calypso Biotech - Menafn.com
Market Leaders: What is the target price for Equillium Inc stock2025 Trade Ideas & Expert Curated Trade Setups - baoquankhu1.vn
Aug Technicals: Can Equillium Inc reach all time highs this yearBond Market & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Market Outlook: Is Equillium Inc stock a buy before product launchesIndex Update & Technical Pattern Recognition Alerts - Bộ Nội Vụ
Does Equillium Inc stock have upside surprise potentialTrade Risk Report & Long-Term Safe Investment Ideas - baoquankhu1.vn
Reviewing Mineralys Therapeutics (NASDAQ:MLYS) and Equillium (NASDAQ:EQ) - Defense World
Will Equillium Inc. stock reach all time highs in 2025Market Trend Report & Accurate Buy Signal Notifications - Улправда
Equillium principal accounting officer Tom Penny sells $8427 in stock - Investing.com India
Equillium principal accounting officer Tom Penny sells $8427 in stock By Investing.com - Investing.com Australia
Why Equillium Inc. stock is favored by top institutionsJuly 2025 Trends & Weekly Consistent Profit Watchlists - Улправда
Will Equillium Inc. stock benefit from sector rotationJuly 2025 Rallies & Low Volatility Stock Recommendations - Улправда
Is Equillium Inc. stock a top pick in earnings seasonWeekly Market Report & Fast Entry Momentum Alerts - Улправда
Can Equillium Inc. stock double in next 5 yearsEarnings Summary Report & Low Risk High Reward Trade Ideas - Улправда
Equillium, Inc. (NASDAQ:EQ) Short Interest Up 22.7% in December - MarketBeat
Equillium (NASDAQ:EQ) COO Christine Zedelmayer Sells 100,000 Shares - MarketBeat
Equillium Inc Stock (EQ) Financials Data
Revenue
Net Income
Cash Flow
EPS
Equillium Inc Stock (EQ) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Zedelmayer Christine | Sr. Vice President and COO |
Feb 19 '26 |
Sale |
1.76 |
185,937 |
328,104 |
191,444 |
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):